Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220005081 220018718 null 0 Curative (C) 2013-11-14 2013-11-14 Trial Unspecified Y N 220027410 TRIAL
220005082 220001994 1.66 80 Curative (C) 2016-04-20 2016-04-20 Trial Unspecified 1 null 220027417 TRIAL
220005083 220001995 1.73 86 Palliative (P) 2014-10-25 2014-11-18 Cytarabine Low Dose N N 220027420 CYTARABINE
220005084 220001995 null null Palliative (P) 2014-11-03 2014-11-04 CYTARABINE 1 N 220027420 CYTARABINE
220005085 220015909 1.72 null Palliative (P) 2016-02-14 2016-02-18 Cytarabine Low Dose 2 N 220027423 CYTARABINE
220005086 220015909 1.7 0 null 2016-10-24 2016-10-24 Cytarabine Low Dose 02 N 220027423 CYTARABINE
220005087 220001996 1.7 91 Disease modification (D) 2016-11-28 2016-11-29 Trial Unspecified 01 N 220027430 TRIAL
220005088 220001996 1.67 null Palliative (P) 2017-02-15 2017-02-27 Cytarabine Low Dose N N 220027430 CYTARABINE
220005089 220001997 1.92 57.5 null 2016-03-10 2016-03-22 Cytarabine Low Dose 02 N 220027432 CYTARABINE
220005090 220001997 1.68 66 Not known (9) 2016-03-23 2016-03-28 Trial Unspecified Y N 220027432 TRIAL
220005091 220001997 1.76 0 Disease modification (D) null 2015-12-26 Cytarabine low (10to20mg/m2) IV/SC N N 220027432 CYTARABINE
220005092 220001998 null 109.1 Disease modification (D) null 2013-07-30 Cytarabine Low Dose N null 220027439 CYTARABINE
220005093 220001998 1.59 91 Curative (C) 2014-04-04 2014-04-05 AML17 TRIAL 01 null 220027439 AML17 TRIAL
220005094 220001998 1.82 60.7 Curative (C) 2016-06-22 2016-06-27 AML17 TRIAL Y N 220027439 AML17 TRIAL
220005097 220002000 1.86 51.2 null 2017-09-05 2017-09-05 Trial Unspecified Y N 220027450 TRIAL
220005098 220002001 null 67.599 Curative (C) 2017-02-26 2017-02-26 AML17 TRIAL 1 N 220027453 AML17 TRIAL
220005099 220002002 null 76.4 Curative (C) 2016-07-08 2016-07-14 Trial Unspecified Y N 220027456 TRIAL
220005100 220011056 null 60.3 Curative (C) 2015-11-07 2015-11-10 AML17 TRIAL N N 220027457 AML17 TRIAL
220005101 220011056 1.69 88.6 Not known (9) 2013-03-19 2013-03-19 LI-1 TRIAL Y N 220027457 TRIAL
220005102 220002003 null 97.6 Palliative (P) 2015-05-16 2015-05-30 Trial Unspecified N N 220027462 TRIAL
220005103 220011057 0 91 Not known (9) 2017-08-18 2017-08-18 Trial Unspecified 1 null 220027463 TRIAL
220005104 220002004 null 81.6 Palliative (P) 2014-04-22 2014-05-21 Cytarabine Low Dose N N 220027467 CYTARABINE
220005105 220002005 1.78 null Palliative (P) 2014-09-29 2014-09-30 Cytarabine Low Dose N N 220027468 CYTARABINE
220005106 220002005 1.88 72.3 Palliative (P) 2015-11-26 2015-11-26 Trial Unspecified 1 N 220027468 TRIAL
220005107 220002006 1.82 86.9 null null 2016-08-16 Cytarabine Low Dose N N 220027473 CYTARABINE
220005108 220002006 0 100.4 Curative (C) 2014-05-17 2014-05-17 Trial Unspecified Y null 220027473 TRIAL
220005109 220002006 1.75 null Palliative (P) 2013-04-07 2013-04-12 Cytarabine Low Dose N N 220027473 CYTARABINE
220005110 220002007 1.65 65 Curative (C) 2015-01-15 2015-01-15 AML17 TRIAL Y N 220027481 AML17 TRIAL
220005111 220002007 1.59 78.6 null 2015-07-18 2015-07-18 Trial Unspecified 1 N 220027481 TRIAL
220005112 220015914 1.6 81.6 Palliative (P) 2014-11-13 2014-11-23 CYTARABINE 2 null 220027484 CYTARABINE
220005113 220002008 1.69 null Palliative (P) 2017-12-18 2017-12-19 Trial Unspecified 1 null 220027485 TRIAL
220005114 220002009 null 96.2 Curative (C) 2014-05-30 2014-05-30 AML17 TRIAL Y null 220027489 AML17 TRIAL
220005115 220002009 1.68 null Palliative (P) 2015-07-20 2015-07-20 Cytarabine Low Dose N N 220027489 CYTARABINE
220005116 220002009 null 61.1 Curative (C) 2013-02-20 2013-02-23 LI-1 TRIAL Y null 220027489 TRIAL
220005117 220002010 null 104 Palliative (P) null 2015-01-01 Cytarabine Low Dose N null 220027493 CYTARABINE
220005118 220011062 1.58 0 Palliative (P) 2016-05-26 2016-05-29 Cytarabine Low Dose 02 N 220027497 CYTARABINE
220005119 220011062 1.56 null Curative (C) 2016-12-13 2016-12-17 Trial Unspecified 01 N 220027497 TRIAL
220005120 220011062 1.57 null null 2014-08-12 2014-08-25 CYTARABINE N N 220027497 CYTARABINE
220005121 220002011 1.58 null Palliative (P) 2015-05-02 2015-05-08 CYTARABINE 2 N 220027501 CYTARABINE
220005122 220002011 1.52 84.25 Curative (C) null 2014-11-18 Cytarabine Low Dose 2 2 220027501 CYTARABINE
220005123 220002011 1.91 62 Curative (C) null 2013-04-10 AML17 TRIAL null null 220027501 AML17 TRIAL
220005124 220018721 null null null 2014-05-14 2014-05-14 AML17 TRIAL N N 220027511 AML17 TRIAL
220005125 220018721 null null Curative (C) 2013-08-16 2013-08-16 AML17 TRIAL 01 N 220027511 AML17 TRIAL
220005126 220002012 null 101.55 Disease modification (D) 2013-08-25 2013-08-31 Trial Unspecified Y N 220027516 TRIAL
220005127 220002013 null 72.6 Palliative (P) 2015-05-27 2015-05-27 Trial Unspecified 01 N 220027517 TRIAL
220005128 220002013 1.66 15.7 null 2017-03-23 2017-03-23 LI-1 TRIAL 01 N 220027517 TRIAL
220005129 220002014 1.75 72.6 Not known (9) 2013-08-12 2013-08-29 LI-1 TRIAL Y N 220027519 TRIAL
220005130 220002015 0 null Palliative (P) null 2015-08-18 Cytarabine low (10to20mg/m2) IV/SC 02 N 220027520 CYTARABINE
220005131 220002015 1.57 83.9 null 2014-03-31 2014-04-05 Cytarabine Low Dose 99 null 220027520 CYTARABINE
220005132 220002016 0 0 Palliative (P) 2013-06-05 2013-06-06 CYTARABINE 02 N 220027526 CYTARABINE